Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
20.40
+2.04 (11.11%)
At close: Jul 30, 2026, 4:00 PM EDT
21.82
+1.42 (6.96%)
Pre-market: Jul 31, 2026, 7:21 AM EDT

Scribe Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024
Period Ending
Mar '26 Dec '25 Dec '24
Cash & Equivalents
20.3812.812.6
Short-Term Investments
29.3545.1792.57
Cash & Short-Term Investments
49.7357.96105.17
Cash Growth
--44.89%-
Accounts Receivable
1.287.093.12
Other Receivables
0.240.260.4
Receivables
1.527.353.52
Prepaid Expenses
1.151.621.69
Total Current Assets
52.466.93110.37
Property, Plant & Equipment
9.3210.0713.18
Long-Term Deferred Charges
-0.53.6
Other Long-Term Assets
3.490.710.82
Total Assets
65.2178.22127.97
Accounts Payable
5.124.573.79
Accrued Expenses
4.336.715.98
Current Portion of Long-Term Debt
40.5535.34-
Current Portion of Leases
1.331.291.12
Current Income Taxes Payable
0.07-0.64
Current Unearned Revenue
28.3321.0923.41
Other Current Liabilities
-0.070.09
Total Current Liabilities
79.7269.0635.02
Long-Term Debt
--34.47
Long-Term Leases
4.464.86.09
Long-Term Unearned Revenue
11.719.9449.01
Other Long-Term Liabilities
7.717.498.88
Total Liabilities
103.59101.28133.47
Common Stock
0.010.010.01
Additional Paid-In Capital
16.314.249.95
Retained Earnings
-175.05-157.71-135.9
Comprehensive Income & Other
-0.040.07
Total Common Equity
-158.74-143.42-125.86
Shareholders' Equity
-38.38-23.06-5.5
Total Liabilities & Equity
65.2178.22127.97
Total Debt
46.3341.4341.68
Net Cash (Debt)
3.416.5463.49
Net Cash Growth
--73.96%-
Net Cash Per Share
1.396.8126.50
Filing Date Shares Outstanding
2.472.452.42
Total Common Shares Outstanding
2.472.452.42
Working Capital
-27.32-2.1275.36
Book Value Per Share
-64.31-58.51-52.06
Tangible Book Value
-158.74-143.42-125.86
Tangible Book Value Per Share
-64.31-58.51-52.06
Machinery
12.8312.8212.39
Leasehold Improvements
4.944.944.94
SEC Filings: 10-K · 10-Q